JP2021008481A5 - - Google Patents

Download PDF

Info

Publication number
JP2021008481A5
JP2021008481A5 JP2020164124A JP2020164124A JP2021008481A5 JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5 JP 2020164124 A JP2020164124 A JP 2020164124A JP 2020164124 A JP2020164124 A JP 2020164124A JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5
Authority
JP
Japan
Prior art keywords
nucleic acid
medicament according
tumor
time
gitrl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020164124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021008481A (ja
JP7111384B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021008481A publication Critical patent/JP2021008481A/ja
Publication of JP2021008481A5 publication Critical patent/JP2021008481A5/ja
Priority to JP2022112196A priority Critical patent/JP2022137203A/ja
Application granted granted Critical
Publication of JP7111384B2 publication Critical patent/JP7111384B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020164124A 2015-01-09 2020-09-29 悪性腫瘍の治療に対する方法 Active JP7111384B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022112196A JP2022137203A (ja) 2015-01-09 2022-07-13 悪性腫瘍の治療に対する方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562101850P 2015-01-09 2015-01-09
US62/101,850 2015-01-09
US201562126300P 2015-02-27 2015-02-27
US62/126,300 2015-02-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017536882A Division JP2018504403A (ja) 2015-01-09 2016-01-08 悪性腫瘍の治療に対する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022112196A Division JP2022137203A (ja) 2015-01-09 2022-07-13 悪性腫瘍の治療に対する方法

Publications (3)

Publication Number Publication Date
JP2021008481A JP2021008481A (ja) 2021-01-28
JP2021008481A5 true JP2021008481A5 (enExample) 2021-05-06
JP7111384B2 JP7111384B2 (ja) 2022-08-02

Family

ID=56356515

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017536882A Pending JP2018504403A (ja) 2015-01-09 2016-01-08 悪性腫瘍の治療に対する方法
JP2020164124A Active JP7111384B2 (ja) 2015-01-09 2020-09-29 悪性腫瘍の治療に対する方法
JP2022112196A Pending JP2022137203A (ja) 2015-01-09 2022-07-13 悪性腫瘍の治療に対する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017536882A Pending JP2018504403A (ja) 2015-01-09 2016-01-08 悪性腫瘍の治療に対する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022112196A Pending JP2022137203A (ja) 2015-01-09 2022-07-13 悪性腫瘍の治療に対する方法

Country Status (9)

Country Link
US (1) US20180000895A1 (enExample)
EP (2) EP3799879B1 (enExample)
JP (3) JP2018504403A (enExample)
CA (1) CA2973390A1 (enExample)
DK (1) DK3242947T3 (enExample)
ES (1) ES2809734T3 (enExample)
MX (1) MX383277B (enExample)
PL (1) PL3242947T3 (enExample)
WO (1) WO2016112359A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180000895A1 (en) * 2015-01-09 2018-01-04 Oncosec Medical Incorporated Method for the treatment of malignancies
DK3474760T3 (da) 2016-06-27 2023-03-20 Galvanize Therapeutics Inc Generator og et kateter med en elektrode til at behandle en lungepassage
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
EP4552592A3 (en) 2017-12-26 2025-06-18 Galvanize Therapeutics, Inc. Optimization of energy delivery for various applications
KR102793500B1 (ko) * 2018-05-02 2025-04-14 그랜드 디케이드 디벨로프먼츠 리미티드 전기천공 시스템, 방법, 및 장치
WO2020033715A1 (en) * 2018-08-08 2020-02-13 Cedars-Sinai Medical Center Compositions and methods for treating cancer and autoimmune diseases
CN114007535A (zh) 2019-04-18 2022-02-01 盖乐世公司 用于治疗异常组织的装置、系统和方法
CA3147592A1 (en) 2019-07-16 2021-01-21 Galary, Inc. Treatment of the reproductive tract with pulsed electric fields
CN114127121B (zh) 2019-08-12 2025-04-11 北京恩瑞尼生物科技股份有限公司 用于通过cd39表达细胞的adcc靶向促进和增强t细胞介导的免疫反应的方法和组合物
WO2021074695A1 (en) 2019-10-16 2021-04-22 Avacta Life Sciences Limited PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
CN115348844A (zh) 2020-04-08 2022-11-15 盖能适治疗股份有限公司 脉冲电场波形操作和使用
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
WO2023057946A1 (en) 2021-10-07 2023-04-13 Avacta Life Sciences Limited Serum half-life extended pd-l1 binding polypeptides
WO2023153876A1 (ko) 2022-02-10 2023-08-17 주식회사 아피셀테라퓨틱스 Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
CA3248580A1 (en) 2022-04-29 2023-11-02 Purinomia Biotech, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISEASES AND DISORDERS CAUSED BY EOSINOPHIL ACTIVITY

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993434A (en) * 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US20030049696A1 (en) 2001-06-07 2003-03-13 Norment Anne M. Regulatory T cells and uses thereof
US8209006B2 (en) 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
US7245963B2 (en) 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US20110142887A1 (en) * 2009-12-15 2011-06-16 Immunovative Therapies Ltd. Methods and compositions for liquidation of tumors
CN1798502A (zh) * 2003-05-30 2006-07-05 南佛罗里达大学 治疗恶性肿瘤的方法
US8802643B1 (en) 2003-05-30 2014-08-12 University Of South Florida Method for the treatment of malignancies
US8101169B2 (en) 2005-02-23 2012-01-24 The Board Of Trustees Of The Leland Stanford Junior University Ocular gene therapy using avalanche-mediated transfection
US7923251B2 (en) 2005-02-23 2011-04-12 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for avalanche-mediated transfer of agents into cells
WO2007120368A2 (en) * 2006-01-09 2007-10-25 The Regents Of The University Of California Immunostimulatory combinations for vaccine adjuvants
JPWO2010030002A1 (ja) * 2008-09-12 2012-02-02 国立大学法人三重大学 外来性gitrリガンド発現細胞
CN104245719B (zh) * 2011-12-12 2016-09-14 宾夕法尼亚大学托管会 包含改进的il-12基因构建体的组合物和疫苗、免疫治疗剂及其使用方法
US20180000895A1 (en) * 2015-01-09 2018-01-04 Oncosec Medical Incorporated Method for the treatment of malignancies

Similar Documents

Publication Publication Date Title
Mir Bases and rationale of the electrochemotherapy
CN113853174B (zh) 用于选择性细胞消融的时间多路复用波形
Liebetanz et al. Anticonvulsant effects of transcranial direct‐current stimulation (tDCS) in the rat cortical ramp model of focal epilepsy
AU2007224275B2 (en) Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
US6697670B2 (en) Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
P. Spugnini et al. Electrochemotherapy as first line cancer treatment: experiences from veterinary medicine in developing novel protocols
CN116867544A (zh) 通过在少于一半的时间在峰值强度处施加肿瘤治疗场(TTField)来增加TTField的功效
Hofmann et al. Electroporation therapy of solid tumors
JP2019500170A5 (enExample)
Fregni et al. Effects of transcranial direct current stimulation coupled with repetitive electrical stimulation on cortical spreading depression
Burnette et al. The immunology of ablative radiation
NO922441D0 (no) Fremgangsmaate og apparat for pulset, iontoforetisk avgivelse av medikamenter
Cha et al. Plasmid IL-12 electroporation in melanoma
YANAGISAWA et al. Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75)
US11931569B2 (en) Method for changing blood brain barrier permeability
WO2004110371A3 (en) Method for the treatment of malignancies
CN107185107A (zh) 一种超声直流电离子导入系统
Giannola et al. Physical methods to promote drug delivery on mucosal tissues of the oral cavity
JP2024156669A (ja) 神経刺激システム
Spinks et al. Problem of dural scarring in recording from awake, behaving monkeys: a solution using 5-fluorouracil
Baranski et al. Studies on the combined effects of microwaves and some drugs on bioelectric activity of the rabbit central nervous system
Miyazaki et al. Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin
Cemazar et al. 24 Electroporation for Electrochemotherapy and Gene Therapy
Oteri et al. Impact of electro-neuro-feedback on postoperative outcome of impacted lower third molar surgery
CN118202817A (zh) 压电剪切稀化材料组合物以及使用方法